[Treatment for hypertension in patients with renal diseases].
Nakamura
Satoko
S
Division of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center.
D018674:Adrenergic Antagonists / Q000008:administration & dosage*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D018753:Diet, Protein-Restricted; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000008:administration & dosage*; D005081:Exercise Therapy; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000628:therapy; D007674:Kidney Diseases / Q000150:complications*; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis / Q000009:adverse effects; D013565:Sympatholytics / Q000008:administration & dosage*
D018674:Adrenergic Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D013565:Sympatholytics